However, with the introduction of PSA screening, the lymph node metastasis rate has dropped from 40% to 20% in newly diagnosed patients, which makes pelvic lymph node dissection exempt for most patients and reduces postoperative complications. The gene discussed is KLK3; the disease is metastatic malignant neoplasm in the lymph nodes.